Abbott ABT Diagnostic Products — Goodwill, non-deductible
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Abbott in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The source filing: Abbott’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:02 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050134
The total amount of goodwill reported was $35.2 billion at June 30, 2026, and $24.0 billion at December 31, 2025. Goodwill increased by $11.4 billion in the first six months of 2026 due to the completion of the Exact Sciences acquisition. Foreign currency translation adjustments decreased goodwill by $0.2 billion in the first six months of 2026. The amount of goodwill related to reportable segments at June 30, 2026, was $2.7 billion for the Established Pharmaceutical Products segment, $0.3 billion for the Nutritional Products segment, $15.0 billion for the Diagnostic Products segment, and $17.3 billion for the Medical Devices segment. The Diagnostic Products segment includes the amount of goodwill related to the Exact Sciences acquisition. There were no reductions of goodwill relating to impairments in the first six months of 2026.
Item 1. Financial Statements and Supplementary Data
FAQ
- What is Abbott's diagnostic products — goodwill, non-deductible?
- Abbott (ABT) reported diagnostic products — goodwill, non-deductible of $15B in Q2 2026.
- How has Abbott's diagnostic products — goodwill, non-deductible changed year-over-year?
- Abbott's diagnostic products — goodwill, non-deductible increased by 316.7% year-over-year, from $3.6B to $15B.
- What is the long-term trend for Abbott's diagnostic products — goodwill, non-deductible?
- Over 4 years (2021 to 2025), Abbott's diagnostic products — goodwill, non-deductible has grown at a -1.4% compound annual growth rate (CAGR), from $15.1B to $14.3B.
- What does diagnostic products — goodwill, non-deductible mean?
- The portion of goodwill arising from acquisitions within the diagnostics segment that cannot be deducted for tax purposes. This represents the premium paid over the fair value of net identifiable assets that does not provide a future tax shield.
Ask your AI about Abbott's diagnostic products — goodwill, non-deductible.
Connect your AI assistant and compare segments, right in your chat.
